R
RAPT THERAPEUTICS INC
NASDAQ: RAPT (RAPT Therapeutics, Inc.)
最近更新时间: 23小时之前11.38
-0.08 (-0.70%)
| 前收盘价格 | 11.46 |
| 收盘价格 | 11.40 |
| 成交量 | 17,591 |
| 平均成交量 (3个月) | 105,126 |
| 市值 | 188,200,160 |
| 价格/销量 (P/S) | 411.22 |
| 股市价格/股市净资产 (P/B) | 1.09 |
| 52周波幅 | |
| 利润日期 | 7 Aug 2025 |
| 稀释每股收益 (EPS TTM) | -19.84 |
| 总债务/股东权益 (D/E MRQ) | 2.16% |
| 流动比率 (MRQ) | 21.11 |
| 营业现金流 (OCF TTM) | -108.63 M |
| 杠杆自由现金流 (LFCF TTM) | -65.95 M |
| 资产报酬率 (ROA TTM) | -44.72% |
| 股东权益报酬率 (ROE TTM) | -75.60% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看跌 |
| Biotechnology (全球的) | 混合的 | 看跌 | |
| 股票 | RAPT Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
0.8
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 1.0 |
| 平均 | 0.75 |
|
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 0.42% |
| 机构持股比例 | 99.41% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 30 Jun 2025 | 2,794,000 |
| Column Group Llc | 30 Jun 2025 | 1,328,613 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 38.00 (Wells Fargo, 233.92%) | 购买 |
| 中 | 27.00 (137.26%) | |
| 低 | 9.00 (UBS, -20.91%) | 保留 |
| 平均值 | 23.80 (109.14%) | |
| 总计 | 3 购买, 2 保留 | |
| 平均价格@调整类型 | 10.59 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| UBS | 12 Aug 2025 | 9.00 (-20.91%) | 保留 | 10.90 |
| Wells Fargo | 08 Aug 2025 | 38.00 (233.92%) | 购买 | 9.81 |
| JP Morgan | 30 Jul 2025 | 14.00 (23.02%) | 保留 | 11.32 |
| LifeSci Capital | 22 Jul 2025 | 31.00 (172.41%) | 购买 | 12.28 |
| HC Wainwright & Co. | 10 Jul 2025 | 27.00 (137.26%) | 购买 | 8.62 |
| 日期 | 类型 | 细节 |
|---|---|---|
| 27 Aug 2025 | 公告 | RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences |
| 07 Aug 2025 | 公告 | RAPT Therapeutics Reports Second Quarter 2025 Financial Results |
| 23 Jun 2025 | 公告 | RAPT Therapeutics Names Two Industry Veterans to its Board of Directors |
| 13 Jun 2025 | 公告 | RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split |
| 04 Jun 2025 | 公告 | RAPT Therapeutics to Participate in Upcoming Investor Conferences |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合